A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome
article
OA: closed
CC0
⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This randomized, placebo-controlled, crossover trial evaluated danazol's efficacy in treating premenstrual syndrome symptoms.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (46)
- A clinical trial using danazol for the treatment of premenstrual tension via openalex
- Danazol and the premenstrual syndrome. via openalex
- Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes via openalex
- Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. via openalex
- Indications for drug therapy in premenstrual syndrome patients. via openalex
- Low dose danazol in the treatment of the premenstrual syndrome via openalex
- Role of danazol in relieving the premenstrual syndrome. via openalex
- The absorption, distribution and metabolic fate of danazol in rats, monkeys and human volunteers. via openalex
- The medical management of menorrhagia. via openalex
- The Premenstrual Syndrome via openalex
- Treatment of the premenstrual syndrome: A double blind placebo controlled cross over study using danazol via openalex
- doi:10.1097/00001721-199102000-00035 via openalex
- doi:10.1016/0165-6147(91)90504-l via openalex
- doi:10.1016/s0002-9378(86)80040-0 via openalex
- doi:10.1192/bjp.157.6.934 via openalex
- doi:10.1016/s0015-0282(16)53638-3 via openalex
- doi:10.2307/2987883 via openalex
- doi:10.1016/s0015-0282(16)55948-2 via openalex
- doi:10.1192/bjp.155.5.700 via openalex
- doi:10.1192/pb.10.4.81 via openalex
- doi:10.1097/00006254-198801000-00018 via openalex
- doi:10.1192/s0007125000018225 via openalex
- doi:10.1136/bmj.307.6917.1471 via openalex
- doi:10.1176/ajp.141.2.163 via openalex
- W6601518277 via openalex
- W6638325711 via openalex
- W6649514666 via openalex
- W6832762914 via openalex
- doi:10.1016/s0015-0282(16)43869-0 via openalex
- doi:10.1016/0272-7358(88)90050-5 via openalex
- doi:10.2307/2530762 via openalex
- doi:10.1136/pgmj.55.640.87 via openalex
- doi:10.1001/jama.1984.03350190041017 via openalex
- doi:10.1016/s0197-2456(80)80004-3 via openalex
- doi:10.1016/0002-9378(81)90611-6 via openalex
- doi:10.1016/0306-4530(85)90036-8 via openalex
- doi:10.1210/jcem-72-2-252 via openalex
- doi:10.1097/00006842-196811000-00006 via openalex
- doi:10.1016/s0033-3182(85)72792-2 via openalex
- doi:10.1192/bjp.156.2.282a via openalex
- W1782987856 via openalex
- doi:10.1111/j.1600-0447.1980.tb00605.x via openalex
- doi:10.1016/0035-9203(87)90400-7 via openalex
- doi:10.1136/bmj.1.4818.1007 via openalex
- doi:10.2307/2531186 via openalex
- doi:10.1016/0165-6147(84)90515-7 via openalex
Cited by (4)
Source provenance
- openalex
- last seen: 2026-05-11T05:39:31.692385+00:00
- unpaywall
- last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0
· commercial use OK